DVL3 and colorectal carcinoma: The results showed that the migratory and invasive potential were elevated in CRC cells treated with TGF-β1 (10ng/mL), while TGF-β1-induced migration and invasion were inhibited by knockdown of DVL3 using shRNA (Fig. 3A, B).